Roots Analysis has announced the addition of “Medical Device Batteries: Focus on Implants and Wearable Medical Devices – Market Distribution by Battery Chemistry (Lithium, Zinc Air, Nickel and Others), Rechargeability (Rechargeable and Non-Rechargeable), Application (Hearing Aids, Patient Monitoring Devices, Drug Delivery Devices, Cardiovascular Medical Devices and Others) and Key Geographies (North America, Europe, Asia Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2020-2030” report to its list of offerings.
Battery-operated medical devices, such as cochlear implants, defibrillators, insulin pumps and pacemakers, have redefined 21st century healthcare, adding to the user convenience factor and offering profitable value propositions for developers. Battery technologies have simultaneously evolved, with modern power-storage cells having improved safety features and the potential to be used for longer durations.
Key Market Insights
More than 930 batteries, designed for use in medical devices, are currently available / under development
More than 75% of the aforementioned batteries that are intended for implants and wearable medical devices, have lithium based chemistries. The majority of batteries captured in the report (62%) are intended for hearing aids; this is followed by those used in patient monitoring devices (17%) and drug delivery devices (12%).
Over 50 companies, across the world, claim to be engaged in developing medical device batteries
Majority (45%) of these battery developers are located in the Asia Pacific region, primarily in China, while Europe (29%) and North America (27%) almost have an equal number of innovators focused in this field. More than 40% of the industry stakeholders are very large firms.
Get Latest Market Insights: https://www.rootsanalysis.com/reports/medical-device-batteries-market/request-customization.html